111 related articles for article (PubMed ID: 10206299)
1. The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer.
Partridge M; Emilion G; Pateromichelakis S; A'Hern R; Lee G; Phillips E; Langdon J
Br J Cancer; 1999 Apr; 79(11-12):1821-7. PubMed ID: 10206299
[TBL] [Abstract][Full Text] [Related]
2. Patient-specific mutation databases for oral cancer.
Partridge M; Emilion G; Falworth M; A'Hern R; Phillips E; Pateromichelakis S; Langdon J
Int J Cancer; 1999 Jun; 84(3):284-92. PubMed ID: 10371348
[TBL] [Abstract][Full Text] [Related]
3. Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer.
Partridge M; Emilion G; Pateromichelakis S; A'Hern R; Phillips E; Langdon J
Oral Oncol; 1998 Mar; 34(2):77-83. PubMed ID: 9682768
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of D9S162: molecular predictor for treatment response in oral carcinoma.
Murali A; Sailasree R; Sebastian P; Rejnish Kumar R; Varghese BT; Kannan S
Oral Oncol; 2011 Jul; 47(7):571-6. PubMed ID: 21592845
[TBL] [Abstract][Full Text] [Related]
5. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity.
Wu CL; Sloan P; Read AP; Harris R; Thakker N
Cancer Res; 1994 Dec; 54(24):6484-8. PubMed ID: 7987846
[TBL] [Abstract][Full Text] [Related]
6. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
7. LOH at 3p correlates with a poor survival in oral squamous cell carcinoma.
Partridge M; Emilion G; Langdon JD
Br J Cancer; 1996 Feb; 73(3):366-71. PubMed ID: 8562343
[TBL] [Abstract][Full Text] [Related]
8. [Molecular analysis of TP53, D9S1747, D9S162 and RPS6 in oral squamous cell carcinoma].
Wang XH; Zhang YY; Chen XM; Sun ZJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Jan; 46(1):42-6. PubMed ID: 21418946
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma.
Weber F; Xu Y; Zhang L; Patocs A; Shen L; Platzer P; Eng C
JAMA; 2007 Jan; 297(2):187-95. PubMed ID: 17213402
[TBL] [Abstract][Full Text] [Related]
10. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
11. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis.
Roz L; Wu CL; Porter S; Scully C; Speight P; Read A; Sloan P; Thakker N
Cancer Res; 1996 Mar; 56(6):1228-31. PubMed ID: 8640803
[TBL] [Abstract][Full Text] [Related]
12. Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions.
Zhou X; Jordan RC; Li Y; Huang BL; Wong DT
Cancer Genet Cytogenet; 2005 Aug; 161(1):86-9. PubMed ID: 16080964
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.
Coon SW; Savera AT; Zarbo RJ; Benninger MS; Chase GA; Rybicki BA; Van Dyke DL
Int J Cancer; 2004 Aug; 111(2):206-12. PubMed ID: 15197772
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas.
Chien HT; Liao CT; Huang SF; Chen IH; Liu TY; Jou YS; Wang HM; Hsieh LL
Genes Chromosomes Cancer; 2011 May; 50(5):358-69. PubMed ID: 21344537
[TBL] [Abstract][Full Text] [Related]
15. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer.
Nakanishi H; Wang XL; Imai FL; Kato J; Shiiba M; Miya T; Imai Y; Tanzawa H
Anticancer Res; 1999; 19(1A):29-34. PubMed ID: 10226521
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
17. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma.
El-Naggar AK; Coombes MM; Batsakis JG; Hong WK; Goepfert H; Kagan J
Oncogene; 1998 Jun; 16(23):2983-7. PubMed ID: 9662330
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in mammary serine protease inhibitor (maspin) and p53 at chromosome 17 and 18 in oral cavity squamous cell carcinoma.
Choi KY; Choi HJ; Chung EJ; Lee DJ; Kim JH; Rho YS
Head Neck; 2015 Sep; 37(9):1239-45. PubMed ID: 24801268
[TBL] [Abstract][Full Text] [Related]
19. Frequent gene deletions in potentially malignant oral lesions.
Emilion G; Langdon JD; Speight P; Partridge M
Br J Cancer; 1996 Mar; 73(6):809-13. PubMed ID: 8611386
[TBL] [Abstract][Full Text] [Related]
20. Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population.
Tran TN; Liu Y; Takagi M; Yamaguchi A; Fujii H
J Oral Pathol Med; 2005 Mar; 34(3):150-6. PubMed ID: 15689228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
